CNC
TEVA icon

Citizens & Northern Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Citizens & Northern Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-24,406
Closed -$1.29M – 83
2014
Q1 		$1.29M Sell
24,406
-15,440
-39% -$714K 1.01% 53
2013
Q4 		$1.6M Buy
39,846
+1,900
+5% +$74.8K 1.21% 40
2013
Q3 		$1.43M Buy
37,946
+1,188
+3% +$46.3K 1.16% 46
2013
Q2 		$1.44M Buy
+36,758
New +$1.43M 1.2% 41

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Citizens & Northern Corp's TEVA Position: Q2 2014 in Review

Citizens & Northern Corp sold out of Teva Pharmaceuticals (TEVA) in Q2 2014, closing a stake of 24,406 shares — an estimated $1.29M sold.

Citizens & Northern Corp first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $1.6M in Q4 2013. 779 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

  • Citizens & Northern Corp reported no remaining Teva Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Citizens & Northern Corp sold 24,406 Teva Pharmaceuticals shares in Q2 2014, an estimated $1.29M.
  • Citizens & Northern Corp first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Citizens & Northern Corp's Teva Pharmaceuticals position peaked at $1.6M in Q4 2013.
  • 779 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2014.

Based on Citizens & Northern Corp's 13F filing for Q2 2014, filed 13 Aug 2014.